Aerie Pharmaceuticals Inc

CIK 1337553 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aerie Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 10, 2023SC 13G/A0001193805-23-000142
Dec 1, 202215-12G0001140361-22-044004
Nov 21, 202240001209191-22-058188
Nov 21, 20228-K0001140361-22-042430
Nov 21, 202240001209191-22-058165
Nov 21, 2022S-8 POS0001140361-22-042448
Nov 21, 202240001209191-22-058186
Nov 21, 2022S-8 POS0001140361-22-042446
Nov 21, 2022S-8 POS0001140361-22-042449
Nov 21, 202240001209191-22-058183
Nov 21, 2022S-8 POS0001140361-22-042453
Nov 21, 202240001209191-22-058154
Nov 21, 202225-NSE0001354457-22-000658
Nov 21, 202240001209191-22-058172
Nov 21, 202240001209191-22-058191
Nov 21, 202240001209191-22-058180
Nov 21, 2022S-8 POS0001140361-22-042447
Nov 21, 2022S-8 POS0001140361-22-042455
Nov 21, 2022S-8 POS0001140361-22-042457
Nov 21, 202240001209191-22-058160
Nov 21, 202240001209191-22-058189
Nov 21, 202240001209191-22-058176
Nov 21, 2022S-8 POS0001140361-22-042445
Nov 18, 20228-K0001140361-22-042330
Nov 10, 2022SC 13G/A0000895421-22-000591